$VRCA
Verrica Pharmaceuticals Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is VRCA down today? It is at $4.82 (-0.82%). See the catalyst behind the move, real-time alerts the moment VRCA spikes, and full due diligence on VRCA — key stats, earnings, dilution and insider activity. Free.
Get free $VRCA alerts the moment volume spikes
Be first to know when $VRCA makes an unusual move. Create a free account to track $VRCA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $4.82
- Change today
- -0.82%
- Previous close
- $4.86
- 52-week range
- $3.28 – $9.82
- Market cap
- $83M
- Institutional own.
- 28.20%
- Total held
- 28.7%
- Tradeable float
- 12.2M 71% of shares · after <1% insiders + 28% institutions
- Avg daily volume
- 175K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 7.7x
- 15mthin
- 30x
- 1hthin
- 5.5x
- 1D
- --
Get free VRCA + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $VRCA down today?
Here is the latest on VRCA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VRCA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystVerrica Pharmaceuticals Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 18, 2026 · 5 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying11 open-market buys6 buys, 0 sells last 3 months (13/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Rosenberg Noah L. Officer | Bought (open market) | +2K 0.01% of company | added 31% | 9K | $10K at $4.92 | Aug 18, 26 |
Kirby John J. Officer | Bought (open market) | +5K 0.03% of company | added 26% | 24K | $25K at $4.93 | Aug 18, 26 |
Rosenberg Noah L. Officer | Bought (open market) | +4K 0.02% of company | added 100% | 7K | $21K at $4.91 | Aug 17, 26 |
Rieger Jayson Officer | Bought (open market) | +5K 0.03% of company | added 2.5% | 208K | $25K at $4.91 | Aug 17, 26 |
Zawitz David Officer | Bought (open market) | +6K 0.03% of company | added 29% | 27K | $30K at $4.98 | Aug 17, 26 |
Rieger Jayson Officer | Bought (open market) | +20K 0.1% of company | added 11% | 203K | $101K at $5.06 | Aug 14, 26 |
Kirby John J. Officer | Acquired (grant/award) | +10K 0.06% of company | added 100% | 19K | n/a | Dec 23, 25 |
Kirby John J. Officer | Bought (open market) | +4K 0.02% of company | added 65% | 9K | $15K at $4.24 | Nov 25, 25 |
Rieger Jayson Officer | Bought (open market) | +94K 0.5% of company | added 100% | 183K | $400K at $4.24 | Nov 25, 25 |
Manning Paul B Director | Bought (open market) | +1.38M 8.0% of company | added 53% | 3.96M | $5.8M at $4.24 | Nov 25, 25 |
Manning Paul B Director | Bought (open market) | +2.75M 16.0% of company | added 100% | 3.80M | $11.7M at $4.24 | Nov 25, 25 |
Zawitz David Officer | Bought (open market) | +10K 0.06% of company | added 91% | 21K | $42K at $4.24 | Nov 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $VRCA runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 14,756,230 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
- At-the-market (ATM) program — sells new shares into the market gradually over time
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$VRCA Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$VRCA Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to VRCA
Comparable names in pharmaceutical preparations, closest in size first.
VRCA stock FAQ
Why is $VRCA down today?
Here is the latest on VRCA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VRCA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the VRCA stock price today?
VRCA last traded at $4.82, down 0.82% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live VRCA alerts?
The VRCA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VRCA 0 times in the last 30 days.
What exchange is VRCA on?
VRCA (Verrica Pharmaceuticals Inc. Common Stock) trades on XNAS, with a market cap of about $83M in the PHARMACEUTICAL PREPARATIONS sector.
Is VRCA good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VRCA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.